IFRS net income vs Sales growth at constant exchange rates

In 2026, IFRS net income worldwide was 343 million EUR; sales growth at constant exchange rates was 17.8%.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time in 2026 . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

IFRS net income

Unit: million EUR · 2 observations

Line chart
IFRS net incomeIFRS net income. 2 observations from Q1 2026 to Q2 2026, ranging from 343 million EUR to 1,957 million EUR. Latest value 343 million EUR (Q2 2026). million EUR 0 500 1,000 1,500 2,000 8 Jan 15 Jan 22 Jan 5 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 1,957 343
IFRS net incomeIFRS net income. 2 observations from Q1 2026 to Q2 2026, ranging from 343 million EUR to 1,957 million EUR. Latest value 343 million EUR (Q2 2026). million EUR 0 500 1,000 1,500 2,000 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 1,957 343
IFRS net incomeIFRS net income. 2 observations from Q1 2026 to Q2 2026, ranging from 343 million EUR to 1,957 million EUR. Latest value 343 million EUR (Q2 2026). million EUR 0 500 1,000 1,500 2,000 8 Jan 22 Mar Feb 2026 Mar 2026 1,957 343
View the underlying data
IFRS net income
Period Type Value
Q1 2026 Actual 1,957 million EUR
Q2 2026 Actual 343 million EUR
Source: Sanofi · CC BY 4.0 · Full series

Sales growth at constant exchange rates

Unit: % · 2 observations

Line chart
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 15 Jan 22 Jan 5 Feb 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 22 Mar Feb 2026 Mar 2026 3% 18%
View the underlying data
Sales growth at constant exchange rates
Period Type Value
Q1 2026 Actual 3%
Q2 2026 Actual 17.8%
Source: Roche, Sanofi · CC BY 4.0 · Full series

Shared periods

Side by side

Only one period is published for both series. Comparing anything else would mean comparing different years.

Period IFRS net income Sales growth at constant exchange rates
2026 343 million EUR 17.8%

Provenance

Where these numbers come from

IFRS net income

Net profit or loss for the period attributable to equity holders under International Financial Reporting Standards.

2 observations in Global · source organisations: Sanofi

Sales growth at constant exchange rates

Percentage change in sales calculated at constant exchange rates over the specified period.

2 observations in Global · source organisations: Roche, Sanofi

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related